GAMCO Investors Updates Gabelli Healthcare Trust Preferred Share Holdings
Ticker: GRX · Form: SC 13D/A · Filed: Jan 8, 2024 · CIK: 1391437
| Field | Detail |
|---|---|
| Company | Gabelli Healthcare & Wellnessrx Trust (GRX) |
| Form Type | SC 13D/A |
| Filed Date | Jan 8, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 17 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-holding, amendment, preferred-shares, institutional-ownership
TL;DR
**GAMCO still holds Gabelli Healthcare Trust preferred shares, signaling continued confidence.**
AI Summary
GAMCO Investors, Inc. and its affiliates, including GAMCO Asset Management, Inc., filed an amended Schedule 13D/A on January 8, 2024, indicating their continued beneficial ownership of Preferred Shares in The Gabelli Healthcare & Wellness Rx Trust. The filing, triggered by an event on December 26, 2023, updates their disclosure regarding their holdings, which are managed on behalf of investment advisory clients. This matters to shareholders because GAMCO is a significant holder, and their ongoing involvement suggests continued confidence in the trust, potentially influencing market perception and stability.
Why It Matters
This filing confirms GAMCO's continued significant stake in the Gabelli Healthcare & Wellness Rx Trust, signaling their ongoing commitment and potentially providing stability for other investors.
Risk Assessment
Risk Level: low — This is an amendment to an existing filing, indicating no new major acquisition or disposition, thus posing low immediate risk.
Analyst Insight
Investors should note GAMCO's continued, stable ownership of the preferred shares, which suggests a long-term institutional interest. This could be a positive signal for the stability of the trust's preferred shares, but doesn't indicate any immediate catalysts for price movement.
Key Numbers
- 36246K509 — CUSIP Number (identifies one class of Preferred Shares of The Gabelli Healthcare & Wellness Rx Trust)
- 36246K608 — CUSIP Number (identifies another class of Preferred Shares of The Gabelli Healthcare & Wellness Rx Trust)
- 13-4044521 — I.R.S. Identification No. (identifies GAMCO Asset Management, Inc.)
Key Players & Entities
- GAMCO Investors, Inc. (company) — the reporting person filing the SC 13D/A
- The Gabelli Healthcare & Wellness Rx Trust (company) — the issuer of the securities
- GAMCO Asset Management, Inc. (company) — a reporting person and affiliate of GAMCO Investors, Inc.
- David Goldman (person) — person authorized to receive notices for GAMCO Investors, Inc.
- Preferred Shares (other) — the class of securities being reported
Forward-Looking Statements
- GAMCO Investors will maintain its significant stake in The Gabelli Healthcare & Wellness Rx Trust's Preferred Shares. (GAMCO Investors, Inc.) — high confidence, target: Q2 2024
- The Gabelli Healthcare & Wellness Rx Trust's Preferred Shares will likely experience stable trading due to continued institutional holding. (The Gabelli Healthcare & Wellness Rx Trust) — medium confidence, target: Q2 2024
FAQ
What is the purpose of this SC 13D/A filing?
This SC 13D/A is an amendment (Amendment No. 3) to a Schedule 13D, updating information regarding the beneficial ownership of Preferred Shares in The Gabelli Healthcare & Wellness Rx Trust by GAMCO Investors, Inc. and its affiliates.
Who are the primary reporting persons in this filing?
The primary reporting persons are GAMCO Investors, Inc. and GAMCO Asset Management, Inc., as indicated in the filing's 'FILED BY' section and Item 1 of the Schedule 13D.
What specific securities are covered by this filing?
This filing covers the Preferred Shares of The Gabelli Healthcare & Wellness Rx Trust, identified by CUSIP Numbers 36246K509 and 36246K608.
When was the event that triggered this filing?
The date of the event which required the filing of this statement was December 26, 2023.
What is the source of funds used by the reporting persons for these holdings?
The source of funds is '00-Funds of investment advisory clients', meaning GAMCO manages these shares on behalf of its clients rather than for its own proprietary account.
Filing Stats: 4,365 words · 17 min read · ~15 pages · Grade level 11 · Accepted 2024-01-08 16:07:26
Filing Documents
- grxpref_04.htm (SC 13D/A) — 137KB
- 0000807249-24-000005.txt ( ) — 139KB
Security and Issuer
Item 1. Security and Issuer This Amendment No. 4 to Schedule 13D on the Preferred Shares of The Gabelli Healthcare & Wellness Rx Trust (4.00% Series E Cumulative Preferred Shares and 5.20% Series G Cumulative Preferred Shares) (the "Issuer") and is being filed on behalf of the undersigned to amend the Schedule 13D, as amended (the "Schedule 13D") which was originally filed on December 22, 2020. Unless otherwise indicated, all capitalized terms used herein but not defined shall have the same meanings as set forth in Schedule 13D.
Identity and Background
Item 2. Identity and Background
to Schedule 13D is amended, in pertinent part, as follows
Item 2 to Schedule 13D is amended, in pertinent part, as follows: This statement is being filed by various entities which except for LICT Corporation ("LICT) and CIBL, Inc. ("CIBL"), engage in various aspects of the securities business, primarily as investment adviser to various institutional and individual clients, including registered investment companies and pension plans, and as general partner or the equivalent of various private investment partnerships or private funds and as a registered broker-dealer. Certain of these entities may also make investments for their own accounts. Mario J. Gabelli ("Mario Gabelli") is deemed to directly or indirectly control these entities through his ownership interest. The foregoing persons in the aggregate often own beneficially more than 5% of a class of equity securities of a particular issuer. Although several of the foregoing persons are treated as institutional investors for purposes of reporting their beneficial ownership on the short-form Schedule 13G, the holdings of those who do not qualify as institutional investors may exceed the 1% threshold presented for filing on Schedule 13G or implementation of their investment philosophy may from time to time require action which could be viewed as not completely passive. In order to avoid any question as to whether their beneficial than on the short-form Schedule 13G and thereby to provide more expansive disclosure than may be necessary. (a), (b) and (c) - This statement is being filed by one or more of the following persons: GGCP, Inc. ("GGCP"), GGCP Holdings LLC ("GGCP Holdings"), GAMCO Investors, Inc. ("GBL"), Associated Capital Group, Inc. ("AC"), Gabelli Funds, LLC ("Gabelli Funds"), GAMCO Asset Management Inc. ("GAMCO"),
Interest In Securities Of The Issuer
Item 5. Interest In Securities Of The Issuer
to
Item 5 to Schedule 13D is amended, in pertinent part, as follows: (a) The aggregate number of Securities to which this Schedule 13D relates is 2,214,000 Preferred Shares representing 41.52% of the 5,332,000 Preferred Shares outstanding as reported by the Issuer. The Reporting Persons beneficially own those Securities as follows: Name Preferred shares % Mario Gabelli GAMCO Foundation AC 1,400,000 300,000 314,000 200,000 26.26% 5.63% 5.89% 3.75% Mario Gabelli is deemed to have beneficial ownership of the Securities owned beneficially by each of the foregoing persons. AC, GBL and GGCP are deemed to have beneficial ownership of the Securities owned beneficially by each of the foregoing persons other than Mario Gabelli and the Foundation. (b) Each of the Reporting Persons and Covered Persons has the sole power to vote or direct the vote and sole power to dispose or to direct the disposition of the Securities reported for it, either for its own benefit or for the benefit of its investment clients or its partners, as the case may be. (c) Information with respect to all transactions in the Securities which were effected during the past sixty days or since the most recent filing on Schedule 13D, whichever is less, by each of the Reporting Persons and Covered Persons is set forth on Schedule II annexed hereto and incorporated herein by reference. (e) Not applicable. 8 Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 8, 2024 GGCP, INC. GABELLI FOUNDATION, INC. MARIO J. GABELLI By: /s/ David Goldman David Goldman Attorney-in-Fact GAMCO INVESTORS, INC. By: /s/ Peter D. Goldstein Peter D. Goldstein General Counsel – GAMCO Investors, Inc. ASSOCIATED CAPITAL GROUP, INC. GAMCO ASSET MANAGEMENT INC. By: /s/ Douglas R. Jamieson Douglas R. Jamieson President & Chief Executive Officer – Associated Capital Grou